Keyphrases
Virus
100%
Viral Infection
100%
Antiviral Immune Response
100%
Interferon Response
100%
Pathogenic Viruses
100%
Immune State
100%
Knock-in Mouse Model
50%
Viral
50%
APOBEC
50%
Chikungunya Virus (CHIKV)
50%
Zika Virus
50%
Basal Conditions
50%
Therapeutic Target
50%
COVID-19
50%
Human Viruses
50%
Togaviridae
50%
Negative Regulator
50%
Rhabdoviridae
50%
Type I Interferon Response
50%
MHC Class I Antigen Presentation
50%
Chikungunya Virus Infection
50%
Stress Granules
50%
Cell-intrinsic
50%
HERC5
50%
Coronaviridae
50%
IFITM
50%
Viral Restriction Factors
50%
Viperin
50%
Herpesviridae
50%
Tetherin
50%
Irgm1
50%
SAMHD1
50%
Antiviral Process
50%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
100%
Virus Infection
66%
Interferon
66%
Infection
33%
Knockout Mouse
33%
Chikungunya
33%
Chikungunya Virus
33%
Interferon Type I
33%
SARS Coronavirus
33%
Zika Virus
33%
Rhabdoviridae
33%
Togaviridae
33%
Herpesviridae
33%
Coronaviridae
33%
Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptide Like
33%
Bone Marrow Stromal Antigen 2
33%
Medicine and Dentistry
Antivirus Agent
100%
Virus Infection
66%
Interferon
66%
Infection
33%
Chikungunya
33%
Interferon Type I
33%
Chikungunya Virus
33%
Antigen Presentation
33%
Herpesviridae
33%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Coronaviridae
33%
Rhabdoviridae
33%
Zika Virus
33%
Togaviridae
33%
Bone Marrow Stromal Antigen 2
33%
Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptide Like
33%
Immunology and Microbiology
Viral Disease
100%
interferon
100%
Chikungunya Virus
66%
Knockout Mouse
33%
Antigen Presentation
33%
Zika Virus
33%
Herpesviridae
33%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Rhabdoviridae
33%
Togaviridae
33%
Coronaviridae
33%
Tetherin
33%
SAMHD1
33%